Detalhe da pesquisa
1.
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.
Ann Hematol
; 103(3): 737-747, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263537
2.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647134
3.
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Ann Hematol
; 101(10): 2231-2239, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042023
4.
Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
Liver Int
; 41(9): 2171-2178, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173316
5.
Transient palindromic rheumatism induced by chimeric antigen receptor-T cell therapy.
Rheumatology (Oxford)
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261627
6.
Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.
Clin Exp Rheumatol
; 37(3): 465-473, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418124
7.
Correction to: Lowrisk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Ann Hematol
; 101(12): 2819-2820, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264368
8.
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study.
Lancet Haematol
; 11(2): e136-e146, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190832
9.
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing.
Cancers (Basel)
; 15(15)2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568719
10.
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
Clin Cancer Res
; 29(20): 4057-4067, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698881
11.
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Blood Adv
; 7(19): 5799-5811, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450374
12.
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
Cancers (Basel)
; 14(17)2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077644
13.
Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia.
Leuk Res
; 121: 106923, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933910
14.
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study.
Blood Adv
; 6(2): 373-375, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753179
15.
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score.
Blood Cancer J
; 12(11): 156, 2022 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385103
16.
The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS.
Leuk Res
; 70: 34-36, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29775844